התחייבויות לטווח ארוך להון עצמי: IRADIMED Inc. (IRMD)

IRADIMED CORPORATION (IRMD) sources components for infusion systems from third-party suppliers while maintaining final assembly in-house. The business also delegates the creation of electronic modules and global logistics to external contractors. This price action shown below, where the indicator stands at 0.00, is complemented by the effective leadership of Roger Susi, who ensures high profitability through exclusive technological solutions in the specialized medical equipment sector.

This indicator measures the proportion of long-term liabilities within the equity structure, allowing for an assessment of financial leverage and the business development financing strategy. For IRADIMED CORPORATION (IRMD), which combines in-house assembly with component outsourcing, the long-term debt-to-equity ratio reflects the balance between investments in production capacity and financial autonomy, confirming the overall stability of the company's capital.